Comments
Loading...
Evome Medical Analyst Ratings and Price Targets | OTC:LNDZF | Benzinga
Evome Medical Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Evome Medical Corp from these most-recent analyst ratings.
Analyst Ratings for Evome Medical
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Evome Medical (LNDZF) stock?
There is no price target for Evome Medical
What is the most recent analyst rating for Evome Medical (LNDZF)?
There is no analyst for Evome Medical
When was the last upgrade for Evome Medical (LNDZF)?
There is no last upgrade for Evome Medical
When was the last downgrade for Evome Medical (LNDZF)?
There is no last downgrade for Evome Medical.
When is the next analyst rating going to be posted or updated for Evome Medical (LNDZF)?
There is no next analyst rating for Evome Medical.
Is the Analyst Rating Evome Medical (LNDZF) correct?
There is no next analyst rating for Evome Medical.
Browse analyst ratings and price targets on all stocks.
